-
effectivehealthcare.ahrq.gov/sites/default/files/hip-fracture-pain_surveillance.pdf
July 08, 2015 - Surveillance Report: CER 30: Comparative Effectiveness of Pain Management for Hip Fracture
AHRQ Comparative Effectiveness Review
Surveillance Program
CER #30: Comparative Effectiveness of Pain Management
Interventions for Hip Fracture …
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/rapid-review-production_white-paper.pdf
February 01, 2015 - EPC Methods: An Exploration of Methods and Context for the Production of Rapid Reviews
Research White Paper
EPC Methods: An Exploration of Methods and Context
for the Production of Rapid Reviews
Research White Paper
EPC Methods: An Exploration of Methods and Context
for…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-report-2-acute-pain.pdf
May 01, 2022 - Systematic Review on Treatments for Acute Pain: Surveillance Report 2
Systematic Review on Treatments for
Acute Pain: Surveillance Report 2
Literature Update Period: November 1, 2021, through January 22, 2022
Background and Purpose
This is the second surveillance report for the 2020 report Treatments for Acute P…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/main-apps-surv-rept-1-acute-pain.pdf
May 01, 2022 - Systematic Review on Treatments for Acute Pain: Surveillance Report 1
Systematic Review on Treatments for
Acute Pain: Surveillance Report 1
Literature Update Period: August 2020 through October 2021
Background and Purpose
This is the first update for the 2020 report Treatments for Acute Pain: A Systematic Review…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/suicide-prevention_research.pdf
October 01, 2016 - Suicide Life Threat
Behav. 2000 Fall;30(3):252-71. PMID:
11079638.
34. Brown KJ, Block AJ. … Suicide Life Threat
Behav. 2000 Fall;30(3):252-71. PMID: 11079638.
16. Brown KJ, Block AJ.
-
effectivehealthcare.ahrq.gov/sites/default/files/diabetes-horizon-scan-high-impact-1306.pdf
January 01, 2016 - Most diabetes mellitus cases fall into one of two broad categories: type 1
diabetes mellitus (T1DM) … Opinions diverged on whether cost of care would rise or fall with these modifications to
exenatide.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/registries-guide-2nd-edition_disposition-comments.pdf
March 03, 2010 - a central
resource such as PIX, someone has to do a review of the greyzone matches
(records that fall
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/cer-212-urinary-incontinence-disposition-comments.pdf
August 08, 2018 - category and behavioral modification into
another, and all nonsurgical/
nonpharmacological treatments fall
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/allergy-seasonal_research-protocol.pdf
March 08, 2012 - States, tree pollens tend to emerge in
the spring, grass pollens in the summer, and weed pollens in the fall
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/migraine-prevention_executive.pdf
June 01, 2013 - J Child Adolesc
Psychopharmacol. 2004 Fall;14(3):359-71. PMID: 15650493.
14.
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/acs-pci-adjunctive-devices_executive.pdf
December 01, 2011 - value with a 95 percent
confidence interval implies that when a
measurement is made 100 times, it will fall
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/methods-guidance-topic-nomination_methods.pdf
November 01, 2012 - Template for Reports Developed
Methods Guide
for Comparative Effectiveness Reviews
Developing and Selecting Topic Nominations for
Systematic Reviews
ii
Comparative Effectiveness Reviews are systematic reviews of existing …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism-adolescents_executive.pdf
August 01, 2012 - 1
Comparative Effectiveness Review
Number 65
Interventions for Adolescents and Young
Adults With Autism Spectrum Disorders
Executive Summary
Background
Autism Spectrum Disorders (ASD)
are among the most common
neurodevelopmental disorders, with an
estimated prevalence of 1 in 110 children
in the United Stat…
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/health-systems-research.pdf
October 01, 2017 - Understanding Health-Systems’ Use of and Need for Evidence To Inform Decisionmaking
White Paper
Understanding Health-Systems’ Use of and
Need for Evidence To Inform Decisionmaking
Research White Paper
Understanding Health-Systems’ Use of and
Need for Evidence To Inform Decisionmaking
Prepared for:
Agency …
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/recombinant-factor-viia_executive.pdf
May 01, 2010 - Layout 1
Background
This report evaluates the level of evidence
currently available to support the
effectiveness and safety of using
recombinant activated coagulation factor
VII (rFVIIa) for clinical indications not
approved by the U. S. Food and Drug
Administration (FDA). rFVIIa is approved
for a variety of uses i…
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/measuring-blood-pressure-surveillance-160412.pdf
May 29, 2025 - A"reduced"heart"rate"variability"is"independently"associated"with"a"blunted"nocturnal"blood"
pressure"fall"in"patients"with"resistant"hypertension
-
effectivehealthcare.ahrq.gov/sites/default/files/technical-brief-36-patient-engagement-comments.pdf
August 26, 2020 - I
went to the Adventist Hospital Fall
Conference in 2016 and listed to Samuel Ross, MD, MS, (Bon
Secours
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/traumatic-brain-injury-rehabilitation-surveillance-160902.pdf
May 29, 2025 - $A$Case"control$Study$Examining$the$Characteristics$of$
Patients$who$Fall$in$an$Inpatient$Traumatic$
-
effectivehealthcare.ahrq.gov/sites/default/files/related_files/autism_disposition-comments.pdf
November 01, 2010 - Analysis (ABA) here is used to
provide a general description of the numerous approaches that may
fall … There
are many studies that do not fall into this limited
category that have made significant
improvements
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/ace-inhibitor-arb-2007_research-2007-1.pdf
January 01, 2007 - Currently,
therapies fall into one of two classes of angiotensin antagonists: the angiotensin-converting … , heart failure, myocardial infarction (MI), diabetes, and renal disease.4,5 Currently,
therapies fall